1,3-dipropyl-8-cyclopentylxanthine has been researched along with Obesity in 3 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The adenosine receptors were studied by using the adenosine antagonist 1,3-[3H]dipropyl-8-cyclopentylxanthine." | 5.28 | Attenuated adenosine-sensitivity and decreased adenosine-receptor number in adipocyte plasma membranes in human obesity. ( Hreniuk, SP; Kaartinen, JM; LaNoue, KF; Martin, LF; Ohisalo, JJ; Ranta, S, 1991) |
| " With chronic administration (6 wk), AUGs decreased 47 and 33% in obese and lean animals, respectively." | 1.30 | A1 adenosine receptor antagonism improves glucose tolerance in Zucker rats. ( Berkich, DA; Crist, GH; LaNoue, KF; Xu, B, 1998) |
| "The adenosine receptors were studied by using the adenosine antagonist 1,3-[3H]dipropyl-8-cyclopentylxanthine." | 1.28 | Attenuated adenosine-sensitivity and decreased adenosine-receptor number in adipocyte plasma membranes in human obesity. ( Hreniuk, SP; Kaartinen, JM; LaNoue, KF; Martin, LF; Ohisalo, JJ; Ranta, S, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thong, FS | 1 |
| Graham, TE | 1 |
| Xu, B | 1 |
| Berkich, DA | 1 |
| Crist, GH | 1 |
| LaNoue, KF | 2 |
| Kaartinen, JM | 1 |
| Hreniuk, SP | 1 |
| Martin, LF | 1 |
| Ranta, S | 1 |
| Ohisalo, JJ | 1 |
1 review available for 1,3-dipropyl-8-cyclopentylxanthine and Obesity
| Article | Year |
|---|---|
The putative roles of adenosine in insulin- and exercise-mediated regulation of glucose transport and glycogen metabolism in skeletal muscle.
Topics: Adenosine; Animals; Diabetes Mellitus; Exercise; Glucose; Glucose Transporter Type 4; Glycogen; GTP- | 2002 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Obesity
| Article | Year |
|---|---|
A1 adenosine receptor antagonism improves glucose tolerance in Zucker rats.
Topics: Adipocytes; Adipose Tissue; Administration, Oral; Animals; Brain; Female; Glucose; Glucose Tolerance | 1998 |
Attenuated adenosine-sensitivity and decreased adenosine-receptor number in adipocyte plasma membranes in human obesity.
Topics: Adenosine; Adenylyl Cyclases; Adipose Tissue; Body Weight; Cell Membrane; Colforsin; Cyclic AMP; Enz | 1991 |